A research study
titled, “Metabolomics
Market by Technique and Application - Global Industry Analysis and Forecast
to 2025” published by Crystal Market Research, states that the metabolomics market
is projected to be around $2.5 billion by 2025.
Metabolomics is identification and quantification of the
complete set of metabolites in a biological system. Metabolomics are used in
wide range of applications such as drug testing, toxicological studies, and
detection of diseases such as Alzheimer’s and necrosis by using biomarkers.
Biomarkers are traceable substances that are inserted into an organism either
for disease diagnostic or to examine health parameters. Metabolomics can also
help in diagnosis of different subtypes of Alzheimer’s disease for permitting
morecontrolled therapies. The biomarkers can be used for diagnosis and
prognosis of malignant tumors. Metabolomics is also used to improve the
detection of various cancers such as kidney, prostate, liver, and pancreas.
Browse full research report with TOC on “Metabolomics
Market by Technique and Application - Global Industry Analysis and Forecast to
2025” at: http://www.crystalmarketresearch.com/report/metabolomics-market
High performance liquid
chromatography (HPLC) segment occupied the largest share of
metabolomics market in 2016 and is expected to maintain its dominance during
forecast period. This can be attributed to number of factors
such as high speed and accuracy of technique. Biomarker discovery segment
occupied the largest share of the overall market in 2016, due to factors such
as enhancement in effectiveness and reliability of metabolic profiling of
biomarkers for drug discovery and diagnosing malfunction metabolites.
U.S. accounted for the major share of the North American
metabolomics market in 2016, owing to factors such as easy availability of technologically
advanced products, rise in adoption rate of personalized medicines, and highly
developed healthcare infrastructure. Emerging markets such as China and India
will exhibit favorable growth during the forecast period with rising emphasis
on biopharmaceutical research and development activities in these countries.
Key players in the global metabolomics market include
LECO Corporation, Agilent Technologies, Inc., Waters Corporation, Bio-Rad
Laboratories, Inc., Thermo Fisher Scientific, Inc., Shimadzu Corporation, Human
Metabolome Technologies, Inc., Metabolon, Inc. and Bruker Corporation. Product
development is the key strategy adopted by the major players operating in the
global market to expand and strengthen their product portfolio and increase
their market share. For instance, in May 2016,Agilent Technologies Inc.
introduced The Agilent 5110 ICP-OES to its lineup of inductively coupled
plasma-optical emission spectrometers. This new system will facilitate more
accurate ICP-OES analysis.Likewise, in November 2016, Metabolon, Inc. launched
the Meta IMD test that speeds up the diagnosis of inherent metabolic disorders.
Request a sample copy of Metabolomics Market Research
Report @ http://www.crystalmarketresearch.com/report-sample/HC0635
Key
Findings of the Research Study:
·
HPLC segment held the largest share of the global
metabolomics market in 2016, owing to accuracy and reliability of the technique.
·
Biomarker discovery segment held the major
share of the metabolomics market in 2016, owing to the high efficiency of
metabolic biomarkers for managing diseases at the metabolic level.
·
North America held around two-fifth of the
global share of the overall market in 2016, due to rise in adoption rate of
personalized medicines and easy access to technologically advanced products.
·
Asia-Pacific market is projected to grow with
the highest CAGR over the forecast period as a result of rise in age related
disorders and prevalence of high unmet medical needs.
Inquire more about this report at: http://www.crystalmarketresearch.com/send-an-enquiry/HC0635
Metabolomics Market Segmentation
By
Technique:
- Separation Techniques
o Capillary Electrophoresis
o High Performance Liquid Chromatography
o Gas Chromatography
o Ultra Performance Liquid Chromatography
- Detection Techniques
o Nuclear Magnetic Resonance Spectroscopy
o Mass Spectrometry
By
Application:
- Drug Assessment
- Nutrigenomics
- Clinical toxicology
- Biomarker Discovery
- Others
By Region:
- North America
o U.S
o Canada
o Mexico
- Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
- Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific
- Rest of the World
o Brazil
o South Africa
o Saudi Arabia
o Turkey
o United Arab Emirates
o Others
Get Customization in the Report At: http://www.crystalmarketresearch.com/customization/HC0635
Related Reports:
Biomarkers Market
by Product by Type, Disease, and Application - Global Industry Analysis and
Forecast to 2025: http://www.crystalmarketresearch.com/report/biomarkers-market
Early Toxicity
Testing Market by Technique and End User - Global Industry Analysis and
Forecast to 2025: http://www.crystalmarketresearch.com/report/early-toxicity-testing-market
About Crystal
Market Research
Crystal Market Research is a U.S. based market research
and business intelligence company. Crystal offers one stop solution for market
research, business intelligence, and consulting services to help clients make
more informed decisions. It provides both syndicated as well as customized
research studies for its customers spread across the globe. The company offers
market intelligence reports across a broad range of industries including
healthcare, chemicals & materials, technology, automotive, and energy.
Contact:
Akhil
V.
304
South Jones Blvd, Suite 1896,
Las
Vegas NV 89107,
United
States
Toll
Free: +1-888-213-4282
Website: http://www.crystalmarketresearch.com
No comments:
Post a Comment